HP
GSK icon

HealthInvest Partners’s GSK GSK Stock Holding History

HealthInvest Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$5.27M Buy
+150,000
New +$5M 10.18% 5

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HealthInvest Partners's GSK Position: Q4 2022 in Review

HealthInvest Partners opened a new position in GSK (GSK) in Q4 2022: 150,000 shares worth $5.27M. The stake represents 10.18% of the portfolio and ranks #5 among its holdings.

813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • HealthInvest Partners held 150,000 shares of GSK worth $5.27M as of Q4 2022.
  • GSK was a new HealthInvest Partners position in Q4 2022.
  • GSK made up 10.18% of HealthInvest Partners's portfolio in Q4 2022, its #5 holding.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.